Skip to content
Ebenbuild logo — Personalized health intelligence for the lung

Ebenbuild

Personalized health intelligence for the lung

Founded 2019 Germany Munchen, Germany 30 employees Total: $5.73M Health Care, Medical Devices

General Information

Company Name Ebenbuild
Founded Year 2019
Location Germany Munchen, Germany
Employees 30
Industries Health Care, Medical Devices
Offices as of Sep 2026
Munchen, Germany
Social

BounceWatch is an independent company data service, not affiliated with Ebenbuild. To contact Ebenbuild, visit ebenbuild.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ebenbuild compare?

A PDF of Ebenbuild and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ebenbuild soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Ebenbuild

Ebenbuild is a digital health tech pioneer striving to revolutionize the field with its slogan, "Precision therapy based on personalized digital twins." Founded in 2019 and headquartered in Germany, Ebenbuild is focused on developing precise, patient-specific simulation models of lungs, known as digital twins of the lungs. Through a digital toolset that integrates physics-based simulation, AI, and data science, the company aims to provide crucial support to decision-makers in the life sciences industry, clinicians, and physicians. Ebenbuild's innovative approach offers a deeper understanding of respiratory diseases and individual pathophysiology, leading to a new class of products and services. These range from in silico trials that can accelerate and de-risk the development of inhaled drugs to personalized treatment options that enhance the chances of survival and recovery for millions of individuals affected by respiratory conditions such as Acute Respiratory Distress Syndrome (ARDS) each year. The company recently secured a Seed Round investment on 31 March 2022, with backing from High-Tech Gründerfonds and Bayern Kapital. This support signals confidence in Ebenbuild's potential to drive significant advancements in the healthcare industry through its cutting-edge approach.

Business keywords: digital health tech, precision therapy, personalized medicine, respiratory diseases, lung simulation models, AI in healthcare, data science in healthcare, in silico trials, drug delivery optimization, clinical decision support, mechanical ventilation personalization, healthcare IT integration, deep tech

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Support Program $2.33M 1
European Innovation Council
01 Mar 2025
Grant $900.00K -
01 Nov 2023
Seed €2.50M 2
Bayern Kapital, HTGF
01 Apr 2022
Support Program Undisclosed 1
EIT Health
01 Jan 2021
Spinout Undisclosed 1
Technical University Munich
01 Apr 2019

Ebenbuild Alternatives & Competitors

View All Alternatives
Ebenbuild vs

Since 1906 our mission is innovating Cure & Care to make patients’ lives better.

Series A
2468 employees
Biotechnology, Health Care
Ebenbuild vs
Strata Oncology
Strata Oncology United States

Strata Oncology is a high-growth, state-of-the art, precision oncology company, delivering a new sta...

Series C
31 employees
Biotechnology, Health Care
Ebenbuild vs

Global fast-growing  solution provider for respiratory health

Seed
39 employees
Health Care, Medical Devices

FAQ About Ebenbuild

Personalized health intelligence for the lung
Ebenbuild was founded in 2019.
Ebenbuild is headquartered in Munchen, Germany.
Ebenbuild operates in Health Care and Medical Devices. Its work centres on digital health tech, precision therapy, personalized medicine and respiratory diseases.
Ebenbuild has approximately 30 employees.
Ebenbuild has completed 5 funding rounds, raising a total of $5.73M.
Top alternatives and competitors to Ebenbuild include Breath Therapeutics, Strata Oncology, Resvent Medical Technology Co.,Ltd, Findair, Predict4Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ebenbuild and Breath Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ebenbuild, https://www.bouncewatch.com/company/ebenbuild, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout